Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Risk Reduction Behavior 1Hot Flashes 1Focus of Study is Healthy Women at Risk for Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Acupuncture Therapy 5Gabapentin 4Venlafaxine Hydrochloride 3Estrogens, Conjugated (USP) 3liposomal amphotericin B 2Tamoxifen 2Magnesium Oxide 2Hypnosis 2Control Groups 2Citalopram 2oxybutynin 1black cohosh root extract 1bazedoxifene 1Zolpidem 1Testosterone 1Tablets 1Soybean Proteins 1Solifenacin Succinate 1Sodium Chloride 1Sertraline 1Progesterone 1Pregabalin 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Mindfulness 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Isoflavones 1Hypericum extract LI 160 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hot Flashes × bazedoxifene × Breast × Clear all
NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

University of Kansas Medical Center

Phase 2 Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡